Why is Ambey Laborator. falling/rising?

As of 16-Sep, Ambey Laboratories Ltd is experiencing a price increase, currently at 42.75, which reflects a rise of 1.35 or 3.26%. The stock has outperformed its sector by 2.71% today, and its delivery volume has increased by 29.03% compared to the 5-day average, indicating rising investor participation. While the stock's performance over the year shows a significant decline of 39.28%, it has seen a modest gain of 4.27% over the past month, suggesting some recovery in the short term. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average, which may indicate a mixed outlook.
In the broader market context, the stock's short-term return of 0.83% over the past week is lower than the benchmark Sensex's return of 1.49%, suggesting that while the stock is rising today, it has not kept pace with the overall market trend recently. The year-to-date performance shows a stark contrast, with Ambey Laboratories down 32.94% compared to the Sensex's gain of 6.74%, highlighting the challenges the company faces relative to the broader market. Overall, while there are signs of positive movement today, the long-term performance remains concerning, and the stock's ability to sustain this upward trend will depend on continued investor interest and broader market conditions.